tiprankstipranks
Trending News
More News >
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Revenue

Compare
587 Followers

Verve Therapeutics Revenue

Verve Therapeutics had a revenue of 13.08M in the quarter ending Dec 31, 2024, with 90.53%. This bring the company's revenue in the last twelve months to 32.33M, Decreased 32.53%. In the fiscal year ending Dec 31, 2024, Verve Therapeutics had annual revenue of 32.33M with 174.98% growth.
Revenue (ttm)
32.33M
Revenue Growth
174.98%
P/S Ratio
11.32
Revenue/Employee
$118,000
Employees
274
Market Cap
$365.84M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202432.33M20.57M+174.98%
Dec 31, 202311.76M9.82M+505.77%
Dec 31, 20221.94M+∞%
Dec 31, 20210.00
Dec 31, 20200.00
Dec 31, 20190.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis